News & Alerts
-
Jan- 2024 -11 January
SyntheticGestalt and Enamine Forge Collaboration to Revolutionize Drug Discovery with AI
SyntheticGestalt, a cutting-edge research and development company specializing in applying artificial intelligence (AI) to the life sciences, has announced a…
Read More » -
11 January
AbbVie Confident in Botox Market Share Amid Rising Competition
In the face of intensifying competition in the aesthetics space, pharmaceutical giant AbbVie (ABBV.N) has expressed confidence in maintaining Botox’s…
Read More » -
11 January
US FDA Temporarily Allows Import of French Syphilis Drug to Address Shortages
In response to the alarming shortage of syphilis treatment drugs in the United States, the U.S. Food and Drug Administration…
Read More » -
9 January
FDA Issues Warning on Toxic Tejocote Root Supplements Contaminated with Yellow Oleander
In September 2023, the Centers for Disease Control and Prevention published a report of several tejocote root products found to…
Read More » -
9 January
Megadyne Medical Products, Inc. Issues Recall for Mega Soft Universal Patient Return Electrode Due to Burn Risks
Megadyne Medical Products, Inc. has initiated a recall of its Mega Soft Universal Patient Return Electrode, Mega Soft Universal Dual,…
Read More » -
9 January
FDA Approves Vaporized Hydrogen Peroxide as Established Sterilization Method for Medical Devices
In a significant development, the U.S. Food and Drug Administration (FDA) has officially recognized vaporized hydrogen peroxide (VHP) as an…
Read More » -
9 January
Chiesi Group and Oak Hill Bio Collaborate on OHB-607, a Neonatal Therapy
Chiesi Group, an international biopharmaceutical and healthcare group, and Oak Hill Bio, a neonatology and rare disease therapeutics company, have…
Read More » -
9 January
AbbVie Introduces PRODUODOPA® for Advanced Parkinson’s Disease in the European Union
AbbVie (NYSE: ABBV), a leading global healthcare company, has announced the launch of PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union. This…
Read More » -
9 January
Medtronic’s Percept™ RC Neurostimulator, Empowered by BrainSense™ Technology, Receives FDA Approval
Medtronic plc, a global leader in healthcare technology, proudly announced today the approval of its Percept™ RC Deep Brain Stimulation…
Read More » -
9 January
Bayer Pushes Forward with U.S. Expansion Despite Setback in Blood Thinner Drug Development
German pharmaceutical giant Bayer (BAYGn.DE) remains undeterred in its plans for expansion into the U.S., reaffirming its commitment to the…
Read More »